Valuable Role of Neutrophil CD64 and Highly Sensitive CRP Biomarkers for Diagnostic, Monitoring, and Prognostic Evaluations of Sepsis Patients in Neonatal ICUs

Table 6

Delta changes (dC) percent for both sepsis neonates without improvement (group 1) and improved sepsis neonates (group 2).

	Sepsis neonates without improvement (Gr1)	Improved sepsis neonates (Gr2)
HB_dC	-6.629 (-13.105–17.85)	-9.43 (-18.246–0.224)	-0.992	0.321
TLC_dC	16.277 (-27.688–45.433)	-5.153 (-35.398–47.281)	-0.851	0.395
ANC_dC	27.174 (5.357–404.03)	-38.235 (-0.56911–0.30303)	-2.415	0.016
Plt_dC	-2.41 (-73.62–13.876)	17.925 (-0.0551–1.07197)	-2.056	0.04
CRP_dC	50 (-25–640.833)	-80 (-100 to -50)	-3.427	0.001
CD64%_dC	0.691 (-4.806–19.154)	-47.423 (-71.136–34.091)	-5.031	<0.0001
CD64 MFI_dC	0.942 (-28.648–47.023)	-26.337 (-47.075–10.106)	-1.65	0.09

Values are presented as the median and IQR.